Notification Letter and Reply Form to Registered Shareholders - Notice of Publication of Interim Report
Filed with HKEX · Stock code 950 · · 2 pages · English and Chinese
The Current Corporate Communication of the Company have been published in English and Chinese languages and are available on the website of The Stock Exchange of Hong Kong Limited (“HKEX”) at www.hkexnews.hk and the Company’s website at http://www.leespharm.com. If you have any difficulty in receiving or gaining access to the Current Corporate Communication posted on the Company’s website for any
Lee's Pharmaceutical Holdings Limited on 6ix
Earlier from Lee's Pharmaceutical
- Interim Report 2026
- Lee's Pharmaceutical Holdings: Connected Transaction - Provision of Financial Assistance
- Lee Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed from Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China
- - Grant of Share Options
- - Establishment of the Group Commercial Operations Centre
Later from Lee's Pharmaceutical
- Notification Letter and Reply Form to Non-Registered Shareholders - Notice of Publication of Interim Report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow Lee's Pharmaceutical into a list and get an email when it puts out news.
Follow Lee's Pharmaceutical